Sonim Q1 revenue $16.7M (+12% seq), GAAP net income $0.5M; adj EBITDA -$3.2M

DNA X, Inc.

2025-Q1 EPS reported $0.08 revenue$16,721,000

Net revenue $16.7M, +12% sequentially; GAAP net income $0.5M vs Q4 2024 loss of $21.6M.
Adjusted EBITDA -$3.2M, improved from -$16.6M in Q4; cash $2.1M.
Raised $6.5M via ATM and debt for expansion and European growth.
XP Pro Thermal 5G orders, Verizon Frontline status, T-Mobile XP3plus launch targeting first responders.
Set to launch five products in Q2 with Tier 1 carriers and distribution partners.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.